4 ms·
TLDR: A test using mice doing a transfusion of blood from younger->older showed signs of rejuvenation. It's still going through clinical trials for humans. An S
by dmix 9y ago
TLDR: A test using mice doing a transfusion of blood from younger->older showed signs of rejuvenation. It's still going through clinical trials for humans. An SF startup is running such a trial with 100 people, each of whom paid $8k.
+ there are critics/skeptics of it's scientific viability as well as the costs considering it's unproven.
Key quote:
> “There's just no clinical evidence [that the treatment will be beneficial],” argues Tony Wyss-Coray, the Stanford neuroscientist behind a key 2014 mice parabiosis study. For one thing, Karmazin’s trial does not use a placebo control group and participants can be as young as 35.